Bluejay Diagnostics Inc (BJDX)

US · Healthcare · Medical Devices

$2.35+7.31%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-2.3M

EPS

$-1.12

Market cap

$2.4M

Forward P/E

0.0

P/B

0.26

Book value

$18.98

EPS (TTM)

$-14.32

52-week high

$28.00

52-week low

$1.84

50-day MA

$3.20

200-day MA

$7.25

Beta

0.92

with an average price target of $256.00.

Insiders

2.03%

Institutions

10.19%

Fund	Stake
Armistice Capital, LLC	2.93%
Heights Capital Management Inc	0.79%
BOOTHBAY FUND MANAGEMENT, LLC	0.61%
Bank of America Corp	0.23%
Vanguard Fiduciary Trust Co	0.23%
Tower Research Capital LLC	0.04%
L1 Global Manager Pty Ltd	0.00%
Caitong International Asset Management Co., Limited.	0.00%

Action	Detail	Date
Split	1 : 4 effective Nov 3, 2026	2026-11-03

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Bluejay Diagnostics Inc — free to start.

Data updated 2026-11-07.